In 2013, Christina Reith, fellow of The Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians, lead authored a paper that addressed in no uncertain terms what effect red tape was having on clinical trials in Europe. Her conclusions were damning – that for academics engaged in carrying out randomised control trials, the most pressing of issues were those …
